E-NOSE for Breath Gas Analysis Under Microgravity Conditions

Status

UNKNOWN

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT02507622

Acronym

E-NOSE

Enrollment

Registered

2015-07-24

Start date

2014-09-30

Completion date

2017-11-30

Last updated

2015-07-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy Volunteers

Brief summary

The main goal of the study is demonstrate that e-Nose system function is not altered in weightlessness and more specifically that gas concentration measurements are the same in weightlessness and normal gravity.

Interventions

OTHERmeasurement of the concentration of C02, CO and NH4, 3 exhaled gas with E-Nose system

OTHERParabolic flight

Study design

Allocation

Intervention model

SINGLE_GROUP

Primary purpose

BASIC_SCIENCE

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

20 Years to 65 Years

Healthy volunteers

Yes

Inclusion criteria

* Healthy volunteers (men or women) * Aged from 20 to 65 * Affiliated to a French Social Security system or, for people living abroad, holding a European Health Insurance Card (EHIC) * Who accepted to take part in the study * Who has given their written stated consent * Who has passed a medical examination similar to a standard aviation medical examination for private pilot aptitude (JAR FCL3 Class 2 medical examination). There will be no additional test performed for subject selection

Exclusion criteria

* Person who took part in a previous biomedical research protocol, of which exclusion period is not terminated * Pregnant women

Design outcomes

Primary

Measure	Time frame
The judgment criteria are the concentration of C02, CO and NH4, 3 exhaled gas	baseline

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026